🌱 KidneyEnergy.com

← brief for 2026-11-12 · Slowing decline

Endothelin Receptor Antagonists in CKD-Associated Resistant Hypertension: Trial Lessons, Safety Boundaries, and Conditions for Future Clinical Testing.

Paper No results yet Peer reviewed

Key takeaways

This review discusses drugs for hard-to-control high blood pressure in kidney disease. It notes that these drugs can cause fluid retention. It also says we do not know if they protect the kidneys long term. There are no new trial results here.

Who did this work

Corrêa LMA · Brandão LKV · Delmiro Silva YR · Zanella J · Pinheiro IM

Source

Paper · PubMed, the drug frontier · 2026 Nov 12
https://pubmed.ncbi.nlm.nih.gov/43018899/